Ardena has appointed Ariane de Ganck as Chief Scientific Officer
Source: PharmaTimes
You may also like
Lilly to acquire AtaiBeckley in deal worth $2.8bn
New €25 Million BioReliance Testing Facility Opens...
StockWatch: Lilly’s Up-to-$3.8B Deal for AtaiBeckley...
Early Genomic Indicators of Praziquantel Resistance in...
Flu Virus Interaction with Host Cell Machinery Mapped...
Protein Protects Against Tau Tangles, Synaptic Loss in...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.